NeoGenomics, Inc. (NEO) Stock Price
NEOStock
$16.65+61.97%52W
Market Cap$2.17B
P/E—
PEG Ratio2.09
Div yield—
Beta1.89
NEO Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)89.50%
Price vs S&P 500 (4W)-12.89%
PEG Ratio2.09
VGM Score55.23
NEO Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $0.03 | $0.05 | +48.63%(+$0.02) | |
| Q1 2026 | $0.00 | $0.01 | +800.90%(+$0.01) | |
| Q4 2025 | $0.04 | $0.06 | +50.00%(+$0.02) | |
| Q3 2025 | $0.02 | $0.03 | +25.79%(+$0.01) | |
| Q2 2025 | $0.02 | $0.03 | +21.85%(+$0.01) |
NEO Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
3.94
3.94
3.94
3.94
Industry Peers — Testing Laboratories(3)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | ROE (TTM) | Revenue Growth (5Y) | Indicated Dividend Yield (Annual) | Price |
|---|---|---|---|---|---|---|---|---|
NEONeoGenomics, Inc. | D | C | A | — | -6.3% | 10.3% | — | $16.65 |
| ULSUL Solutions Inc. | D | B | C | 45.5x | 37.6% | — | 0.7% | $73.31 |
| AIDX20/20 Biolabs, Inc. Common Stock | — | — | F | — | — | — | — | $0.26 |
| BNBXBNB Plus Corp. Common Stock | — | D | D | — | -337.1% | 2.0% | — | $0.10 |
About NeoGenomics, Inc.
NeoGenomics Inc provides comprehensive oncology diagnostic testing and services through laboratories in the United States and United Kingdom. The company's offerings include clinical cancer testing, molecular and next-generation sequencing testing, professional interpretation, consultative services, clinical trial support, validation services, and oncology data solutions.